Everything Lupus: Resource Hub
Living Through COVID-19 With A Weakened Immune System
Read
COVID-19: Canada secures order for five million pills of anti-malaria medication eyed by U.S. as treatment
Read
Quebec pharmacists to begin
Read
COVID-19 Resource Document
Read
COVID-19 Prevention and Risks
Read
Left Behind: Immunocompromised Canadians Living in the Shadow of COVID-19
Read
The Canadian Immunocompromised Advocacy Network (CIAN) – Advocating for immunocompromised people across Canada
Read
Using CyTOF to dissect the interplay between Type I interferon and autoantibody production in Systemic Lupus Erythematosus
Read
Now Enrolling People with Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN) For A Research Study.
Read
COVID-19 VACCINE ROLLOUT
Read
AZD1222 US Phase III trial met primary efficacy endpoint in preventing COVID-19 at interim analysis
Read
Dr. Samir Gupta explains how the four COVID-19 vaccines now approved in Canada work and why efficacy rates aren’t the most important number to look at.
Read
